Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jun;41(6):2795-6.
doi: 10.1128/JCM.41.6.2795-2796.2003.

Initial quality control evaluations for susceptibility testing of Dalbavancin (BI397), an investigational glycopeptide with potent gram-positive activity

Initial quality control evaluations for susceptibility testing of Dalbavancin (BI397), an investigational glycopeptide with potent gram-positive activity

Tamara R Anderegg et al. J Clin Microbiol. 2003 Jun.
No abstract available

PubMed Disclaimer

References

    1. Baquero, F. 1997. Gram-positive resistance: challenge for the development of new antibiotics. J. Antimicrob. Chemother. 39(Suppl. A):1-6. - PubMed
    1. Candiani, G., M. Abbondi, M. Borgonovi, G. Romano, and F. Parenti. 1999. In vitro and in vivo antibacterial activity of BI397, a new semi-synthetic glycopeptide antibiotic. J. Antimicrob. Chemother. 44:179-192. - PubMed
    1. Centers for Disease Control and Prevention. 2002. Staphylococcus aureus resistant to vancomycin: United States, 2002. Morb. Mortal. Wkly. Rep. 51:565-567. - PubMed
    1. Jones, R. N., D. J. Biedenbach, D. M. Johnson, and M. A. Pfaller. 2001. In vitro evaluation of BI397, a novel glycopeptide antimicrobial agent. J. Chemother. 13:244-254. - PubMed
    1. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Document M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.

MeSH terms